Original Research
Published on 19 Feb 2021
Polyporus Umbellatus Protects Against Renal Fibrosis by Regulating Intrarenal Fatty Acyl Metabolites
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.633566
- 4,696 views
- 13 citations
Type at least 3 characters
563 articles
Articles
Original Research
Published on 19 Feb 2021
A Novel Creatinine-Based Equation to Estimate Glomerular Filtration Rate in Chinese Population With Chronic Kidney Disease: Implications for DOACs Dosing in Atrial Fibrillation Patients
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.615953
- 3,953 views
- 9 citations
Original Research
Published on 16 Feb 2021
Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.636154
- 3,925 views
- 12 citations
Mini Review
Published on 10 Feb 2021
Autophagy as a Vital Therapy Target for Renal Cell Carcinoma
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.518225
- 4,041 views
- 14 citations
Original Research
Published on 02 Feb 2021
Involvement of Circulating Exosomal MicroRNAs in Jian-Pi-Yi-Shen Formula Protection Against Adenine-Induced Chronic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.622658
- 4,307 views
- 6 citations
Original Research
Published on 29 Jan 2021
Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.627185
- 5,913 views
- 16 citations
Original Research
Published on 29 Jan 2021
Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-pyroptotic Effects via the TXNIP-NLRP3-GSDMD Axis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.623489
- 6,237 views
- 41 citations
Original Research
Published on 29 Jan 2021
Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.602985
- 4,810 views
- 10 citations
Original Research
Published on 28 Jan 2021
Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.586725
- 6,556 views
- 11 citations
Original Research
Published on 27 Jan 2021
Integrated Fecal Microbiome and Serum Metabolomics Analysis Reveals Abnormal Changes in Rats with Immunoglobulin A Nephropathy and the Intervention Effect of Zhen Wu Tang
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.606689
- 5,904 views
- 24 citations
Review
Published on 26 Jan 2021
Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.598910
- 5,491 views
- 21 citations
Review
Published on 26 Jan 2021
Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.583528
- 6,828 views
- 35 citations
Original Research
Published on 21 Jan 2021
Mitochondrial Iron Overload-Mediated Inhibition of Nrf2-HO-1/GPX4 Assisted ALI-Induced Nephrotoxicity
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.624529
- 19,819 views
- 76 citations
Original Research
Published on 21 Jan 2021
Nanoparticle-Mediated Delivery of Emodin via Colonic Irrigation Attenuates Renal Injury in 5/6 Nephrectomized Rats
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.606227
- 4,607 views
- 15 citations
Original Research
Published on 18 Jan 2021
Astragaloside IV Alleviates Tacrolimus-Induced Chronic Nephrotoxicity via p62-Keap1-Nrf2 Pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.610102
- 5,656 views
- 29 citations
Original Research
Published on 14 Jan 2021
Dissecting Efficacy and Metabolic Characteristic Mechanism of Taxifolin on Renal Fibrosis by Multivariate Approach and Ultra-Performance Liquid Chromatography Coupled With Mass Spectrometry-Based Metabolomics Strategy
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.608511
- 3,132 views
- 10 citations